URI
53
3
ADT
46
-2
INTU
52
-5
NWS
75
6
FE
67
5
BAX
39
4
MTB
55
3
DAL
39
3
DLTR
54
11
XEL
62
5
CB
51
3
SJM
19
3
PEP
38
5
VFC
27
5
URBN
54
-8
DG
33
4
BF.B
48
4
FMC
34
4
MNST
65
3
EBAY
44
2
URI
53
3
ADT
46
-2
INTU
52
-5
NWS
75
6
FE
67
5
BAX
39
4
MTB
55
3
DAL
39
3
DLTR
54
11
XEL
62
5
CB
51
3
SJM
19
3
PEP
38
5
VFC
27
5
URBN
54
-8
DG
33
4
BF.B
48
4
FMC
34
4
MNST
65
3
EBAY
44
2
Financhill
Back

ProShares Short 20+ Yr Treasury Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
58

TBF
ProShares Short 20+ Yr Treasury

Last Price:
$24.47
Seasonality Move:
-2.37%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
$234.56
Seasonality Move:
16.16%
Buy
58
ProShares Short 20+ Yr Treasury (TBF) is a Buy

Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?

  • The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.45. The Score for TBF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • TBF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $234.56. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBF Stock Price Chart

What is ProShares Short 20+ Yr Treasury's stock price today?

  • The ProShares Short 20+ Yr Treasury share price today is $24.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $234.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

TBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 57.98 Buy
Chaikin Money Flow: 11409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.53 - 24.37) Buy
Bollinger Bands (100): (23.56 - 24.66) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.82 Sell
Relative Strength Index (14 RSI): 44.36 Sell
Chaikin Money Flow: 492014 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (233.31 - 270.77) Sell
Bollinger Bands (100): (237.35 - 266.99) Sell

TBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.42 Buy
20-day SMA: 23.99 Buy
50-day SMA: 23.97 Buy
200-day SMA: 23.5 Buy
8-day EMA: 24.3 Buy
20-day EMA: 24.1 Buy
50-day EMA: 24.03 Buy
200-day EMA: 23.77 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 233.46 Buy
20-day SMA: 252.74 Sell
50-day SMA: 253.19 Sell
200-day SMA: 258.73 Sell
8-day EMA: 236.18 Sell
20-day EMA: 244.09 Sell
50-day EMA: 250.46 Sell
200-day EMA: 244.21 Sell

ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.82 per share, an increase next quarter of $1.48 per share, an increase this year of $1.03 per share, and an increase next year of $2.81 per share.

ProShares Short 20+ Yr Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):